Headquartered in Stamford, CT Fiscal year ends December NYSE: SYF synchrony.com
Synchrony Financial (NYSE: SYF) is a consumer financing company that delivers credit and banking products across five sales platforms: Home & Auto, Digital, Diversified & Value, Health & Wellness, and Lifestyle. The company partners with retailers, merchants, and healthcare providers to offer private label credit cards, co-branded consumer credit cards, commercial credit products, and consumer installment loans. Synchrony manages approximately $102 billion in loan receivables and serves approximately 68 million average active accounts. The company funds its lending operations primarily through deposits (83% of funding), securitizations, and unsecured borrowings. Synchrony's partner base includes major retailers and hundreds of thousands of small and mid-sized businesses and healthcare providers across the United States. Updated
Upstart Holdings (NASDAQ:UPST) reported a slight dip in its own credit-stress gauge, the Upstart Macro Index, to 1.49, and the stock is pulling away from the rest of consumer lending, according to…
Sam Stovall says sentiment surveys are a distraction and that one specific corner of the financial system holds the real on-off switch for consumer spending. The signals hiding in this earnings season…
Financial services stocks are quietly running one of the better setups in the market right now. The 10-year Treasury is parked at 4.42%, the 30-year is near 5.00%, and BEA data shows…
Value stocks are generally companies that trade at a price below their fundamental value or what their performance suggests they should be worth. Typically, these are shares of companies with solid fundamentals…
Top-tier U.S. stocks with premier fundamentals and valuations that scream “buy” are hard to come by. When such stocks are discovered, they often skyrocket higher, and I’d argue that most companies that…
Shares of PayPal Holdings, Inc. (NASDAQ:PYPL | PYPL Price Prediction) lost 6.63% over the past month after losing 0.50% and 13.35% the two months prior. That brings the payment processor’s one-year loss…
Wall Street is expecting the Federal Reserve to begin shifting gears in September following the Federal Open Market Committee’s (FOMC) decision to leave interest rates unchanged at the current target rate of…
Premarket trading had all three major U.S. stock indexes lower on Wednesday. Regional banks reporting results have not offered a lot of good news.
Monday's top analyst upgrades and downgrades included Alphabet, Bill, Bumble, Dollar General, FedEx, FMC, Jabil Circuit, Microsoft, Nike, Nvidia, Sarepta Therapeutics, Shopify, Synchrony Financial, Warner Bros. Discovery and Zscaler.
Before U.S. markets open on Monday, Baker Hughes and Synchrony Financial are scheduled to report quarterly results.
Friday's top analyst upgrades and downgrades included ADT, Costco Wholesale, CrowdStrike, Gilead Sciences, Liberty Global, Otis Worldwide, PagSeguro Digital, Palo Alto Networks, Salesforce, Sunrun, Synchrony Financial and Zscaler.
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Biohaven, Edwards Lifesciences, Enphase Energy, Halliburton, Invesco, Liberty Energy, Mattel, Netflix, Permian Resources, Range Resources, Roblox, Synchrony Financial and Visa.
More financial services companies will be reporting quarterly results next week. Here is a look at four set to release earnings reports before U.S. markets open on Monday.
Wednesday's additional top analyst upgrades and downgrades included Bath & Body Works, BioNTech, Caesars, Freeport McMoRan, Gap, Hasbro, and Synchrony Financial.
24/7 Wall St. takes a closer look at a few recent analyst reports on credit card stocks. Considering the recent downturn, one Wall Street analyst sees an incoming recession weighing on these…
Synchrony Financial (NYSE: SYF) is a consumer financing company that delivers credit and banking products across five sales platforms: Home & Auto, Digital, Diversified & Value, Health & Wellness, and Lifestyle.
24/7 Wall St.'s 12-month price target for SYF is $93.37, rated Buy. The Wall Street consensus target is $88.17. SYF price prediction →
